This feature article in Chemistry Today, highlights our peptide chemistry team’s extensive expertise in peptide and macrocyclic drug discovery in a range of therapeutic areas and with an impressive track record in the clinic.
The Power of NMR in Drug Discovery
Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.
Related Posts
